Potomac Capital Management, Inc. Biohaven Pharmaceutical Holding CO Ltd. Transaction History
Potomac Capital Management, Inc.
- $56.8 Million
- Q4 2023
A detailed history of Potomac Capital Management, Inc. transactions in Biohaven Pharmaceutical Holding CO Ltd. stock. As of the latest transaction made, Potomac Capital Management, Inc. holds 19,500 shares of BHVN stock, worth $733,005. This represents 3.38% of its overall portfolio holdings.
Number of Shares
19,500Holding current value
$733,005% of portfolio
3.38%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding BHVN
# of Institutions
11Shares Held
792KCall Options Held
0Put Options Held
0-
Knoll Capital Management, LLC Miami, FL710KShares$26.7 Million17.51% of portfolio
-
Eaton Vance Management Boston, MA35.9KShares$1.35 Million0.01% of portfolio
-
S. Muoio & Co. LLC New York, NY19KShares$713,4583.79% of portfolio
-
Agf Investments LLC Boston, MA11.6KShares$434,5400.16% of portfolio
-
Birchview Capital, LP Burlington, VT7.37KShares$276,8500.34% of portfolio
About Biohaven Pharmaceutical Holding Co Ltd.
- Ticker BHVN
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,645,000
- Market Cap $2.69B
- Description
- Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...